Citigroup Inc Supernus Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 77,439 shares of SUPN stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,439

Previous 54,816 41.27%

Holding current value

$2.8 Million

Previous $1.47 Million 64.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$25.77 - $35.16 $582,994 - $795,424	22,623 Added 41.27%	77,439 $2.41 Million
Q2 2024 Aug 12, 2024	BUY	$25.99 - $33.85 $252,804 - $329,258	9,727 Added 21.57%	54,816 $1.47 Million
Q1 2024 May 10, 2024	BUY	$27.11 - $35.17 $22,040 - $28,593	813 Added 1.84%	45,089 $1.54 Million
Q4 2023 Feb 09, 2024	BUY	$22.72 - $29.68 $369,268 - $482,389	16,253 Added 58.0%	44,276 $1.28 Million
Q3 2023 Nov 09, 2023	SELL	$27.57 - $32.91 $589,860 - $704,109	-21,395 Reduced 43.29%	28,023 $772,000
Q2 2023 Aug 10, 2023	BUY	$29.91 - $38.73 $434,831 - $563,056	14,538 Added 41.68%	49,418 $1.49 Million
Q1 2023 May 11, 2023	SELL	$34.93 - $42.03 $283,876 - $341,577	-8,127 Reduced 18.9%	34,880 $1.26 Million
Q4 2022 Feb 09, 2023	BUY	$31.09 - $37.88 $202,085 - $246,220	6,500 Added 17.8%	43,007 $1.53 Million
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $88,759 - $109,169	3,083 Added 9.22%	36,507 $1.24 Million
Q2 2022 Aug 10, 2022	SELL	$25.33 - $34.25 $488,868 - $661,025	-19,300 Reduced 36.61%	33,424 $966,000
Q1 2022 May 12, 2022	BUY	$28.51 - $32.9 $166,099 - $191,675	5,826 Added 12.42%	52,724 $1.7 Million
Q4 2021 Feb 10, 2022	SELL	$26.37 - $34.22 $99,441 - $129,043	-3,771 Reduced 7.44%	46,898 $1.37 Million
Q3 2021 Nov 10, 2021	BUY	$23.54 - $31.39 $1.19 Million - $1.59 Million	50,669 New	50,669 $1.35 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account